Who invested in Urania Therapeutics?
Urania Therapeutics's investors include Advent France Biotechnology, Bpifrance and Cap Innov'Est.
France · Seed startup
2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$5.8Mraised across 2 rounds since 2019, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Urania Therapeutics's investors include Advent France Biotechnology, Bpifrance and Cap Innov'Est.
Urania Therapeutics has raised $5.8M across 2 rounds since 2019.
Urania Therapeutics's most recent round was a Seed of $1.9M in Jan 2020.
Urania Therapeutics's largest round on record is $3.9M (Seed), in Nov 2019, led by Advent France Biotechnology.
Urania Therapeutics's first round on record, in Nov 2019, was backed by Advent France Biotechnology and Cap Innov'Est.
Urania Therapeutics's latest named round is a Seed, in Jan 2020.
Urania Therapeutics is based in France.
Advent France Biotechnology led the Seed in 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.